Developing new antibodies to prevent HIV infection
Next Generation Development of Broadly Neutralizing HIV Antibodies for Prevention
This study is looking at new types of antibodies that can help fight HIV, with the goal of making treatments and prevention methods better for people living with or at risk of HIV.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Advanced Bioscience Laboratories, INC. NIH-funded |
| Lab location | 1 site (Kensington, United States) |
| Project ID | NIH-11041822 on NIH RePORTER |
What this research studies
This research focuses on creating broadly neutralizing antibodies (bnAbs) that can effectively target and neutralize the HIV virus. By evaluating multiple bnAbs that recognize different parts of the HIV envelope, the research aims to improve treatment and prevention strategies for HIV. The approach includes testing antibodies like VRC01, PGDM1400, and PGT121, and exploring modifications to enhance their effectiveness and longevity in the body. Patients may benefit from these advancements in HIV prevention and treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at high risk of HIV infection or those currently living with HIV who may benefit from enhanced treatment options.
Not a fit: Patients who are not at risk for HIV or those who are already receiving effective treatment may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective HIV prevention methods and improved treatment options for patients living with HIV.
How similar studies have performed: Previous research has shown promise in using broadly neutralizing antibodies for HIV treatment and prevention, indicating a potential for success in this novel approach.
Where this research is happening
Kensington, United States
- Advanced Bioscience Laboratories, INC. — Kensington, United States (Active)
Researchers
- Principal investigator: Fouts, Timothy — Advanced Bioscience Laboratories, INC.
- Study coordinator: Fouts, Timothy
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.